🇺🇸 Dulcolax (Bisacodyl) in United States

3,658 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 3,658

Most-reported reactions

1. Drug Ineffective — 564 reports (15.42%)
2. Constipation — 533 reports (14.57%)
3. Off Label Use — 462 reports (12.63%)
4. Nausea — 390 reports (10.66%)
5. No Adverse Event — 366 reports (10.01%)
6. Pain — 342 reports (9.35%)
7. Vomiting — 270 reports (7.38%)
8. Fall — 248 reports (6.78%)
9. Diarrhoea — 243 reports (6.64%)
10. Abdominal Pain — 240 reports (6.56%)

Source database →

Frequently asked questions

Is Dulcolax (Bisacodyl) approved in United States?

Dulcolax (Bisacodyl) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Dulcolax (Bisacodyl) in United States?

Brooke Army Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.